Document Detail

Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation.
MedLine Citation:
PMID:  10551379     Owner:  NLM     Status:  MEDLINE    
BACKGROUND/AIMS: Hepatitis B virus (HBV) disease on a liver graft is associated with florid viral replication and graft failure. The aim of this study performed between 1992 and 1995 was to investigate the safety and efficacy of long-term intravenous ganciclovir for HBV infection in liver transplant recipients. METHODS: Twelve patients with HBV re-infection and four with de novo HBV infection were studied. HBV DNA was positive in all (median titer: 437.5 pg/ml) and HBeAg was positive in seven. Intravenous ganciclovir was started after a median of 14.5 months from HBsAg positivation and continued for a median of 10 months. RESULTS: A complete response with HBV DNA negativation was seen in ten cases, a partial response with a decrease of more than 50% of initial HBV DNA levels in four and no response in two. Overall tolerance was good. Among the ten complete responders, two seroconverted for both HBsAg and HBeAg and one for HBsAg alone. Among these ten patients, three were re-transplanted for liver failure: two of them are alive; three had a viral breakthrough during treatment; and four remained HBV DNA negative: two are alive and two died. Partial responders and nonresponders were treated with other antiviral agents and three were re-transplanted, two of them are alive. Overall 12 out of 16 patients (75%) survived with a median follow up of 46 months. CONCLUSIONS: Long-term intravenous ganciclovir can persistently inhibit HBV DNA replication in liver transplant recipients and is well tolerated. Further evaluation should be encouraged, especially for HBV recurrence after first-line treatments.
B Roche; D Samuel; M Gigou; C Feray; V Virot; P Majno; L Serraf; M F David; E Dusseaix; M Reynes; H Bismuth
Related Documents :
11170059 - Novel immunoassay for the detection of hepatitis b surface 'escape' mutants and its app...
2648619 - The role of transplantation in liver disease.
10382639 - Does asian race affect hepatitis b virus recurrence or survival following liver transpl...
12558909 - Adoptive transfer of donor-derived immunity by liver transplantation: a potential avenu...
14997399 - Severe exacerbation of chronic hepatitis b after emergence of lamivudine resistance in ...
3777039 - Hyperkalemia provoked by acute hepatic necrosis.
11791749 - Initial symptoms of acute radiation syndrome in the jco criticality accident in tokai-m...
22934439 - Malignancy in renal transplant recipients: a single-center experience in thailand.
2299799 - Effect of recombinant human erythropoietin on renal function in humans.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of hepatology     Volume:  31     ISSN:  0168-8278     ISO Abbreviation:  J. Hepatol.     Publication Date:  1999 Oct 
Date Detail:
Created Date:  1999-12-06     Completed Date:  1999-12-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8503886     Medline TA:  J Hepatol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  584-92     Citation Subset:  IM    
Centre Hépato-Biliaire, Hôpital Paul Brousse, Faculté de Médecine Paris-Sud, Contrat de Recherche INSERM 98-04, UPRES Foie, Virus Hépatotropes et Cancer, Villejuif, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiviral Agents / adverse effects,  therapeutic use*
DNA, Viral / analysis
Ganciclovir / adverse effects,  therapeutic use*
Hepatitis B / drug therapy*,  immunology,  pathology
Hepatitis B Antigens / analysis
Hepatitis B virus / genetics
Liver / pathology
Liver Transplantation*
Middle Aged
Postoperative Complications / drug therapy*
Prospective Studies
Time Factors
Treatment Outcome
Reg. No./Substance:
0/Antiviral Agents; 0/DNA, Viral; 0/Hepatitis B Antigens; 82410-32-0/Ganciclovir

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Elevated intracellular IFN-gamma levels in circulating CD8+ lymphocytes in patients with fulminant h...
Next Document:  Low HCV replication levels in end-stage hepatitis C virus-related liver disease.